BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mattos ÂZ, Debes JD, Boonstra A, Vogel A, Mattos AA. Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy. World J Gastrointest Oncol 2021; 13(9): 1132-1143 [PMID: 34616518 DOI: 10.4251/wjgo.v13.i9.1132]
URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1132.htm
Number Citing Articles
1
Hassan Mohammed Abushukair, Anwaar Saeed. Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitorsWorld Journal of Gastrointestinal Oncology 2022; 14(6): 1210-1212 doi: 10.4251/wjgo.v14.i6.1210
2
Kotaro Matsumoto, Jun Hayakawa, Tomohiro Akutsu, Kanji Okamoto, Yuta Namura, Tomohiro Kikuyama, Go Saito, Takako Adachi, Ayako Watanabe, Takayuki Tsujikawa, Hiromichi Tsunashima, Nobuhiro Katsukura, Tatsuya Aso, Kentaro Kikuchi, Mikiko Takahashi, Shinpei Doi. Successful Sequential Immunotherapy for Multiple Primary Malignancies (Unresectable Hepatocellular Carcinoma and Esophageal Squamous Cell Carcinoma): A Case ReportInternal Medicine 2025;  doi: 10.2169/internalmedicine.5733-25
3
Nicolò Brandi, Matteo Renzulli. The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2023; 24(10): 8598 doi: 10.3390/ijms24108598
4
Meiling He, Chunfeng Liang, Yadan Pang, Mengjie Jiang, Meiying Long, Zhongqiang Yao, Xiaoting Wang, Ruijun Zhang, Qiaoyuan Wu, Shixiong Liang, Jianxu Li. A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1Journal of Hepatocellular Carcinoma 2024; : 913 doi: 10.2147/JHC.S459683